Evidence map›Paper›PMID 35463144›Full record

ArticleFrontiers in neurology2022

Posterior Reversible Encephalopathy Syndrome in Guillain-Barré Syndrome: Just a Problem of Immunoglobulins? Controversy From Two Atypical Case Reports.

Enrico Belgrado, Ilaria Del Negro, Daniele Bagatto, Simone Lorenzut, Giovanni Merlino, Gian L Gigli, Mariarosaria Valente

Open access · goldAbstract readCase Reports
In one paragraph

Article in Frontiers in neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Enrico BelgradoNeurology Unit, Azienda Sanitaria Universitaria Friuli Centrale, Udine University Hospital, Udine, Italy.
Ilaria Del NegroClinical Neurology Unit, Azienda Sanitaria Universitaria Friuli Centrale, Udine University Hospital, Udine, Italy.
Daniele BagattoNeuroradiology Unit, Department of Imaging, Azienda Sanitaria Universitaria Friuli Centrale, Udine University Hospital, Udine, Italy.
Simone LorenzutNeurology Unit, Azienda Sanitaria Universitaria Friuli Centrale, Udine University Hospital, Udine, Italy.
Giovanni MerlinoClinical Neurology Unit, Azienda Sanitaria Universitaria Friuli Centrale, Udine University Hospital, Udine, Italy.
Gian L GigliClinical Neurology Unit, Azienda Sanitaria Universitaria Friuli Centrale, Udine University Hospital, Udine, Italy.
Mariarosaria ValenteClinical Neurology Unit, Azienda Sanitaria Universitaria Friuli Centrale, Udine University Hospital, Udine, Italy.
Ospedale Santa Maria della Misericordia di Udine · ITUniversity of Udine · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Posterior reversible encephalopathy syndrome (PRES), reversible cerebral vasoconstriction syndrome (RCVS), or the coexistence of these two entities shares similar risk factors and clinical features. For these conditions, a common origin has been supposed. Even if the majority of patients show a favorable course and a good prognosis, a small percentage of cases develop neurological complications. Up to date, only about 30 cases of PRES associated with Guillain-Barré syndrome (GBS) have been reported in the literature. Cases: Here, we present two cases of a particularly aggressive PRES/RCVS overlap syndrome, associated with acute motor axonal neuropathy (AMAN) and acute inflammatory demyelinating polyneuropathy (AIDP) variants of GBS, respectively, presenting with similar initial clinical aspects and developing both an atypical and unfavorable outcome. On MRI examination, the first patient showed typical aspects of PRES, while, in the second case, radiological features were atypical and characterized by diffusion restriction on the apparent diffusion coefficient (ADC) map. The first patient demonstrated rapid worsening of clinical conditions until death; the second one manifested and maintained neurological deficits with a permanent disability. Conclusions: We suggest that PRES may conceal RCVS aspects, especially in most severe cases or when associated with a dysimmune syndrome in which autoimmune system and endothelial dysfunction probably play a prominent role in the pathogenesis. Although the role of IVIg treatment in the pathogenesis of PRES has been proposed, we suggest that GBS itself should be considered an independent risk factor in developing PRES.

Indexed as

clinical neurologyendothelial dysfunctionimmunoglobulinsneuroimagingposterior reversible encephalopathy syndrome

Identifiers

PMID35463144
PMCPMC9020620
OpenAlexW4226128671

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.